B. 1. Lambert, Y. Boutot, and F. , Prise en charge pr??hospitali??re des syndromes coronaires aigus, EMC - Trait?? de m??decine AKOS, vol.3, issue.3
DOI : 10.1016/S1634-6939(08)39060-7

N. Danchin, E. Puymirat, N. Aissaoui, S. Adavane, and E. Durand, ??pid??miologie des syndromes coronaires aigus en France et en Europe, Annales de Cardiologie et d'Ang??iologie, vol.59, pp.37-41, 2010.
DOI : 10.1016/S0003-3928(10)70008-1

E. Antman, J. Bassand, W. Klein, M. Ohman, L. Sendon et al., Myocardial infarction redefined???a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction, Journal of the American College of Cardiology, vol.36, issue.3, pp.959-69, 2000.
DOI : 10.1016/S0735-1097(00)00804-4

S. Charpentier, J. Ducassé, and D. Lauque, Douleur thoracique et syndrome coronaire aigu non ST+ : un diagnostic difficile en m??decine d???urgence, Journal Europ??en des Urgences, vol.23, pp.11-16, 2010.
DOI : 10.1016/S0993-9857(10)70004-2

E. Wiel, N. Assez, and P. Goldstein, Stratégie de prise en charge des syndromes coronariens aigus
DOI : 10.1016/s1959-5182(12)59019-7

E. Durand, A. Delos, A. Chaib, A. Lepillier, S. Beretti et al., Performance assessment of a chest pain unit: Preliminary 2-year experience in the European Georges Pompidou Hospital, Archives of Cardiovascular Diseases, vol.102, issue.12, pp.803-812, 2009.
DOI : 10.1016/j.acvd.2009.09.008

H. Ait-oufella, Z. Mallat, and A. Tedgui, Physiopathologie de l'athérosclérose, EMC-Angéiologie, vol.1, issue.11, 2013.

/. Authors, . Task-force-members, P. Steg, S. James, D. Atar et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Eur Heart J, vol.33, issue.20, pp.2569-619, 2012.

J. Dujardin, J. Cambou, R. Gregor, B. Eastwood, H. Wolf et al., Épidémiologie de l'infarctus du myocarde. EMC -Cardiol Trends in the incidence of acute myocardial infarction between 1984 and 1993 -The Halifax County MONICA Project The incidence of suspected myocardial infarction in Dutch general practice in the period 1978-1994, 1? 9. 10. Bata IR, pp.429-463, 1998.

J. Bassand, C. Hamm, D. Ardissino, E. Boersma, A. Budaj et al., Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Coronary event and case fatality rates in an English population: results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group Prognostic value of the admission electrocardiogram in acute coronary syndromes Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort, 1598?660. 13. Volmink Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation, pp.18-26, 1998.

M. Bahit, C. Granger, and L. Wallentin, Persistence of the prothrombotic state after acute coronary syndromes: Implications for treatment, 205?16. 18. Ferrières J, Cambou JP. Épidémiologie du syndrome coronaire aigu en France, 2002.
DOI : 10.1067/mhj.2002.120767

H. Angéiologie-pedoe, K. Kuulasmaa, P. Amouyel, D. Arveiler, A. Rajakangas et al., Tunstall Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents, Circulation, vol.56, issue.19, 1994.

A. Wagner, . Ruidavetsjb, M. Montaye, A. Bingham, J. Ferrière et al., Evolution de la maladie coronaire en France de):1?15. 22. Classification of atherosclerotic lesions; report of a study group, :415?9. 21, pp.40-411, 1958.

J. Paul and B. Baudin, Physiopathologie de l???ath??roscl??rose et marqueurs pr??coces, Revue Francophone des Laboratoires, vol.2009, issue.409
DOI : 10.1016/S1773-035X(09)70199-6

H. Stary, A. Chandler, R. Dinsmore, V. Fuster, S. Glagov et al., A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis : A Report From the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.15, issue.9, pp.1512-1543, 1995.
DOI : 10.1161/01.ATV.15.9.1512

G. Hennen and . Biochimie-humaine, Introduction biochimique à la médecine interne. Paris : DeBoeck université, 1996.

R. Virmani, F. Kolodgie, A. Burke, A. Farb, and S. Schwartz, Lessons From Sudden Coronary Death : A Comprehensive Morphological Classification Scheme for Atherosclerotic Lesions, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.5, pp.1262-75, 2000.
DOI : 10.1161/01.ATV.20.5.1262

J. Léoni and E. Daubrosse, Physiopathologie de l'athérosclérose : mécanismes et prévention de l'athérothrombose [ThD : Pharmacie]. Besançon, 2001.

R. Virmani, A. Burke, and A. Farb, Sudden cardiac death, Cardiovasc Pathol Off J Soc Cardiovasc Pathol

A. Burke, F. Kolodgie, A. Farb, D. Weber, G. Malcom et al., Healed Plaque Ruptures and Sudden Coronary Death : Evidence That Subclinical Rupture Has a Role in Plaque Progression, 934?40. 30. Bristol-Meyers Squibb. Plavix : monographie scientifique, 1999.
DOI : 10.1161/01.CIR.103.7.934

H. Benamer, S. Boudjelal, K. Chachoua, and H. Akoudad, Physiopathologie et étiopathogénie de l'infarctus du myocarde. EMC -Cardiol, pp.1-14, 2011.
DOI : 10.1016/s1166-4568(11)53117-1

M. Ovize and F. Jamal, André-Fouët X. L'ischémie myocardique-Collège des enseignant de

S. Benhabbouche, C. Da-silva, C. Abrial, M. Ferrera, and R. , Base des phénomènes d'ischémie reperfusion et de la protection myocardique. Ann Françaises Anesthésie Réanimation, pp.2-16, 2011.
DOI : 10.1016/s0750-7658(11)70002-8

A. Burke and R. Virmani, Pathophysiology of Acute Myocardial Infarction. Med Clin North Am, 2007.

M. Ovize, Le préconditionnement : adaptation du cardiomyocyte à l'ischémie. Médecine/sciences, pp.352-360, 1999.
DOI : 10.4267/10608/1345

J. Muller, P. Stone, Z. Turi, J. Rutherford, C. Czeisler et al., Circadian variation in the frequency of onset of acute myocardial infarction Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB) Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group, ):1315?22. 37. Cannon CP253?8. 38. Willich SN, pp.853-861, 1985.

M. Cohen, K. Rohtla, C. Lavery, J. Muller, M. Mittleman et al., Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death Time of onset of symptoms of acute myocardial infarction, Am J Cardiol Am J Cardiol, vol.7966, issue.402, pp.140-144, 1990.

A. Jimenez, G. Tofler, X. Chen, M. Stubbs, H. Solomon et al., Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension Weekly variation of acute myocardial infarction Increased Monday risk in the working population. Circulation Circadian, day-of-week, and seasonal variability in myocardial infarction: comparison between working and retired patients Analysis of possible triggers of acute myocardial infarction (the MILIS study), 22?7. 45. Bernard F, Weber S. L'infarctus du myocarde d'effort, pp.47-52, 1990.

DOI : 10.1016/S0049-3848(97)00185-0

J. Möller, A. Ahlbom, J. Hulting, F. Diderichsen, U. De-faire et al., Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP) Heart Br Card Soc, pp.387-90, 2001.

M. Mittleman, M. Maclure, J. Sherwood, R. Mulry, G. Tofler et al., Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group, ):1720?5. 49. Behar S, 1993.

D. Laurier, Les enquêtes de cohorte : quand, comment ? Sang Thromb Vaiss, pp.175-82, 1998.

S. Yusuf, S. Hawken, S. Ôunpuu, T. Dans, A. Avezum et al., Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, The Lancet, vol.11364, issue.9438, pp.937-52

K. Teo, S. Ounpuu, S. Hawken, M. Pandey, V. Valentin et al., Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study Prise en charge d'une douleur thoracique aux urgences. EMC-Médecine Urgence ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent STsegment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J Unstable angina: good long-term outcome after a complicated early course Frequency and consequences of recording an electrocardiogram >10 minutes after arrival in an emergency room in non-STsegment elevation acute coronary syndromes (from the CRUSADE Initiative), 647?58. 56. Raphaël M1?21. 57. Authors/Task Force Members, pp.1534-1543, 1998.

E. Batard, D. Trewick, J. Gueffet, P. Leconte, and G. Potel, Le syndrome coronarien aigu sans sus-décalage du segment ST aux urgences. Réanimation, pp.507-522, 2004.

N. Assez, F. Rouyer, F. Lapostolle, C. Adriansen, E. Wiel et al., Syndrome coronariens aigus non ST+ Médecine d'urgence, 2007.

B. Mccarthy, J. Wong, and H. Selker, Detecting acute cardiac ischemia in the emergency department, 365?73. 63. Babuin L, Jaffe AS. Troponin: the biomarker of choice for the detection of cardiac injury, 1990.
DOI : 10.7326/0003-4819-105-4-586

M. Panteghini, D. Bunk, R. Christenson, A. Katrukha, R. Porter et al., Standardization of troponin I measurements: an update, Clinical Chemistry and Laboratory Medicine, vol.48, issue.11, pp.1501-1507, 2008.
DOI : 10.1373/clinchem.2006.068437

K. Thygesen, J. Alpert, A. Jaffe, M. Simoons, B. Chaitman et al., Third universal definition of myocardial infarction, European Heart Journal, vol.21, issue.11, pp.2551-67, 2012.
DOI : 10.1016/j.annepidem.2011.08.005

J. Bertinchant and A. Polge, Place des marqueurs biologiques en cardiologie. EMC -Cardiol, 2010.
DOI : 10.1016/s1166-4568(10)53113-9

S. James, B. Lindahl, A. Siegbahn, M. Stridsberg, P. Venge et al., N-Terminal Pro-Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV Substudy, Circulation, vol.108, issue.3, pp.275-81, 2003.
DOI : 10.1161/01.CIR.0000079170.10579.DC

M. Infarction, A. Jaffe, and F. Apple, Universal definition of myocardial infarction. Circulation, 2007.

F. Apple, Edging closer to early optimal patient management with high-sensitivity cardiac troponin assay. Circulation, Jul, vol.12124, issue.2, pp.127-136, 2011.

T. Keller, T. Zeller, D. Peetz, S. Tzikas, A. Roth et al., Sensitive troponin I assay in early diagnosis of acute myocardial infarction Early diagnosis of myocardial infarction with sensitive cardiac troponin assays High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission, ):868?77. 72. Reichlin T, pp.642-50, 2009.

M. Weber, O. Bazzino, N. Estrada, J. De-miguel, R. Salzberg et al., Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome, 81?8. 75. Ray P. Intérêt et limites des biomarqueurs en médecine d'urgence. Prat En Anesthésie Réanimation, 2011.
DOI : 10.1016/j.ahj.2011.04.007

E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A. Jaffe et al., Analytical validation of a highsensitivity cardiac troponin T assay Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay, Clin Chem. Feb Int J Cardiol, vol.1556119, issue.323, pp.154-64, 2007.

G. Lefèvre, J. Fayet, H. Graïne, C. Berny, F. Maupas-schwalm et al., Multicenter evaluation of h-FABP semi-quantitative assay (Cardio Detect) in central laboratory: the point in acute myocardial infarction diagnosis Intérêt de la heart-fatty acid binding protein (h-FABP) dans la prise en charge des syndromes coronariens aigus Médecine Nucléaire, 377?84. 79. Delacour H, 2007.

T. Jernberg, M. Stridsberg, P. Venge, and B. Lindahl, N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation, Journal of the American College of Cardiology, vol.40, issue.3, 2002.
DOI : 10.1016/S0735-1097(02)01986-1

A. Suwaidi, J. Reddan, D. Williams, K. Pieper, K. Harrington et al., Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation, pp.974-80, 2002.

F. Masoudi, M. Plomondon, D. Magid, A. Sales, and J. Rumsfeld, Renal insufficiency and mortality from acute coronary syndromes, American Heart Journal, vol.147, issue.4, pp.623-632, 2004.
DOI : 10.1016/j.ahj.2003.12.010

T. Jernberg, B. Lindahl, S. James, A. Larsson, L. Hansson et al., Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, N Engl J Med, vol.110108349, issue.8517, pp.1595-604, 2003.

C. Heeschen, S. Dimmeler, C. Hamm, M. Van-den-brand, E. Boersma et al., Soluble CD40 ligand in acute coronary syndromes Soluble CD40L: risk prediction after acute coronary syndromes. Circulation, N Engl J Med, vol.348108, issue.88, 2003.

A. Ase, guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology, American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography), 2003.

K. Fresse, M. Caza, J. Serfaty, P. Guérin, and D. Crochet, Imagerie non invasive des artères coronaires. EMC -Radiol Imag Médicale Cardiovasc -Thorac -Cervicale, 1146?62. 90. Warin, pp.1-22, 2003.

U. Hoffmann, F. Bamberg, C. Chae, J. Nichols, I. Rogers et al., Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain, Journal of the American College of Cardiology, vol.53, issue.18, pp.1642-50, 2009.
DOI : 10.1016/j.jacc.2009.01.052

S. Chang, S. Choi, E. Choi, H. Kim, J. Jung et al., Usefulness of 64-slice multidetector computed tomography as an initial diagnostic approach in patients with acute chest pain, 375?83. 93. Bonello L, 2008.
DOI : 10.1016/j.ahj.2008.03.016

M. Dany-michel, Électrocardiogramme d'effort, EMC-Cardiol, vol.1, issue.20, 2004.

E. Van-belle, V. Ennezat, P. Bertrand, and M. , Angine de poitrine stable. EMC -Cardiol, 2011.

G. Diamond and J. Forrester, Exercise Testing Guidelines) Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease, ):1531?40. 98, pp.1350-1358, 1979.

R. Bruce and L. Fisher, Unusual prognostic significance of exercise-induced ST elevation in coronary patients, J Electrocardiol, vol.20, 1986.

R. Gianrossi, R. Detrano, D. Mulvihill, K. Lehmann, P. Dubach et al., Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation The diagnostic accuracy of the exercise electrocardiogram: a meta-analysis of 22 years of research, 87?98. 102. Detrano R, pp.173-206, 1989.

G. Helft and G. Montalescot, Angine de poitrine en dehors de l'athérosclérose coronarienne

1. Maseri, A. Mimmo, R. Chierchia, S. Marchesi, C. Pesola et al., Coronary Artery Spasm as a Cause of Acute Myocardial Ischemia in Man, Chest, vol.68, issue.5, pp.625-658, 1975.
DOI : 10.1378/chest.68.5.625

X. Tabone, G. Helft, and A. Vacheron, A rare course of spastic angina with normal coronary arteries. Ann Cardiol Angéiologie, pp.351-355, 1993.

N. Assez, C. Lemanski-brulin, W. Aboukais, Q. Sebilleau, C. Adriansen et al., Défis de la prise en charge du syndrome coronaire aigu en pré-hospitalier Stratification du risque des syndromes coronaires aigus. Ann Cardiol Angéiologie, 223?31. 107. Danchin N, pp.16-20, 2007.
DOI : 10.1016/s1878-6480(12)70835-2

URL : https://doi.org/10.1016/s1878-6480(12)70835-2

E. Braunwald, Unstable angina. A classification. Circulation, pp.410-414, 1989.

C. Hamm and E. Braunwald, A Classification of Unstable Angina Revisited, Circulation, vol.102, issue.1, pp.118-140, 2000.
DOI : 10.1161/01.CIR.102.1.118

E. Antman, M. Cohen, P. Bernink, C. Mccabe, T. Horacek et al., The TIMI Risk Score for Unstable Angina/Non???ST Elevation MI, 835?42. 111. Bellemain-Appaix A, Collet J-P, Montalescot G. Syndromes coronaires aigus, 2000.
DOI : 10.1001/jama.284.7.835

S. Subherwal, R. Bach, A. Chen, B. Gage, S. Rao et al., 1?21. 112 Baseline Risk of Major Bleeding in Non?ST-Segment?Elevation Myocardial Infarction The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes

E. Antman, J. Beasley, R. Califf, M. Cheitlin, and J. Hochman, AHA Guidelines for the Management of Patients With Unstable Angina and Non?ST-Segment Elevation Myocardial Infarction: Executive, 1873?82. 113. Braunwald E, 2009.

J. Anderson, C. Adams, E. Antman, C. Bridges, R. Califf et al., 2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non???ST-Elevation Myocardial Infarction, Journal of the American College of Cardiology, vol.61, issue.23, pp.179-347, 2012.
DOI : 10.1016/j.jacc.2013.01.014

S. Yusuf, J. Wittes, and L. Friedman, Overview of results of randomized clinical trials in heart disease. I

E. Brandler, L. Paladino, and R. Sinert, Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome? Acad Emerg Med Off J Soc Acad Emerg Med, pp.1-10, 2010.

Z. Chen, H. Pan, Y. Chen, R. Peto, R. Collins et al., Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial, Lancet, vol.366, issue.9497, pp.1622-1654, 2005.

G. Ambrosio, D. Pinto, M. Tritto, I. Agnelli, G. Bentivoglio et al., Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia, 430?8. 119. Borzak S, pp.678-81, 1998.

E. Antman, D. Anbe, P. Armstrong, E. Bates, L. Green et al., AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology, Association Task Force on Practice Guidelines, 1999.

J. Borer, Therapeutic effects of If blockade: Evidence and perspective, Pharmacological Research, vol.53, issue.5, pp.440-445, 2006.
DOI : 10.1016/j.phrs.2006.03.017

A. Trialists-'collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, vol.324, issue.7329, pp.71-86, 2002.
DOI : 10.1136/bmj.324.7329.71

J. Godwin, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial, Lancet. Lancet, vol.373376, issue.1269748, pp.1233-1276, 2009.

G. Gislason, S. Jacobsen, J. Rasmussen, S. Rasmussen, P. Buch et al., Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, 2906?13. 128. Yusuf S patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation, pp.1202-1210, 2001.

G. Montalescot, G. Sideris, C. Meuleman, C. Bal-dit-sollier, N. Lellouche et al., A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non???ST-Segment Elevation Acute Coronary Syndromes, Journal of the American College of Cardiology, vol.48, issue.5, pp.486-501, 2006.
DOI : 10.1016/j.jacc.2006.04.090

N. Abraham, M. Hlatky, E. Antman, D. Bhatt, D. Bjorkman et al., Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation, 2619?33. 134. O'Donoghue ML, 2010.

S. Close, S. Wiviott, L. Shen, J. Walker, and T. Simon, Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet, ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38, 2009.

N. Farid, C. Payne, G. Weerakkody, Y. Li, and J. Brandt, Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel, 1312?9. 136. Small DS, pp.475-84, 2008.

S. Wiviott, D. Trenk, A. Frelinger, O. Donoghue, M. Neumann et al., Prasugrel compared with high loading-and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation- Thrombolysis in Myocardial Infarction 44 trial. Circulation Prasugrel versus clopidogrel in patients with acute coronary syndromes Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes, 2577?85. 140. Cannon CP283?93. 141. Wallentin L, pp.1045-57, 2002.

. Iib, IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy, Eur Heart J, vol.23, issue.18, pp.1441-1449, 2002.

S. Ellis, M. Tendera, M. De-belder, A. Van-boven, P. Widimsky et al., Facilitated PCI in Patients with ST-Elevation Myocardial Infarction, New England Journal of Medicine, vol.358, issue.21, pp.2205-2222, 2008.
DOI : 10.1056/NEJMoa0706816

R. Harrington, R. Becker, C. Cannon, D. Gutterman, A. Lincoff et al., Antithrombotic Therapy for Non???ST-Segment Elevation Acute Coronary Syndromes, Chest, vol.133, issue.6, 2000.
DOI : 10.1378/chest.08-0691

E. Antman, C. Mccabe, E. Gurfinkel, A. Turpie, P. Bernink et al., Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation):1593?601. 148. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group, Oct Lancet, vol.12100347, issue.159001, pp.561-569, 1996.

M. Cohen, C. Demers, E. Gurfinkel, A. Turpie, G. Fromell et al., A comparison of lowmolecular-weight heparin with unfractionated heparin for unstable coronary artery disease Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease, 701?7. 151. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, 1997.

G. Montalescot, J. Collet, M. Tanguy, A. Ankri, L. Payot et al., Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin. Circulation, 2004.

J. Ferguson, R. Califf, E. Antman, M. Cohen, C. Grines et al., Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial, Jul JAMA J Am Med Assoc, vol.27110292, issue.1541, pp.45-54, 2004.

S. Murphy, C. Gibson, D. Morrow, F. Van-de-werf, I. Menown et al., Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study, Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction, p.6, 2004.

S. , C. S. Afzal, R. Pogue, and J. , Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial Bivalirudin for patients with acute coronary syndromes Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes, acute coronary syndromes774?82. 162. Rao SV, 2006.

M. Moscucci, K. Fox, C. Cannon, W. Klein, J. López-sendón et al., Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE), European Heart Journal, vol.24, issue.20, pp.1815-1838, 2003.
DOI : 10.1016/S0195-668X(03)00485-8

S. Rao, O. Grady, K. Pieper, K. Granger, C. Newby et al., Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events, Am J Cardiol Eur Heart J, vol.9631, issue.1656, pp.667-75, 2005.

T. Warkentin and J. Kelton, Temporal aspects of heparin-induced thrombocytopenia, N Engl J Med, 2001.

F. Schiele, A. Vuillemenot, P. Kramarz, Y. Kieffer, T. Anguenot et al., Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopenia, American Journal of Hematology, vol.82, issue.1, 1995.
DOI : 10.1093/ajcp/96.3.394

E. Topol, D. Moliterno, H. Herrmann, E. Powers, C. Grines et al., Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization, New England Journal of Medicine, vol.344, issue.25, pp.1888-94, 2001.
DOI : 10.1056/NEJM200106213442502

Y. Li, F. Spencer, and R. Becker, Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition, American Heart Journal, vol.143, issue.4, 2002.
DOI : 10.1067/mhj.2002.120299

D. Moliterno and E. Topol, A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: Rationale and design of the TARGET study, American Heart Journal, vol.140, issue.5, 2000.
DOI : 10.1067/mhj.2000.110094

S. Jubelirer, B. Koenig, and M. Bates, Acute profound thrombocytopenia following C7E3 Fab (abciximab) therapy: Case reports, review of the literature and implications for therapy, American Journal of Hematology, vol.87, issue.3, 1999.
DOI : 10.1161/01.CIR.95.4.809

J. Blankenship, G. Wood, C. Frey, S. Demko, and F. Menapace, Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis Defining the role of chest pain units, Am Heart J. J Am Coll Cardiol, vol.6114037, issue.328, pp.206-217, 2000.

F. Lapostolle, K. Tazarourte, and F. Adnet, Quelle place pour les ????Chest Pain Unit???? dans la fili??re fran??aise de prise en charge des syndromes coronaires??? Le point de vue des urgentistes, La Presse M??dicale, vol.42, issue.6, pp.1039-1080, 2013.
DOI : 10.1016/j.lpm.2013.03.007

G. Montalescot, L. Bolognese, D. Dudek, P. Goldstein, C. Hamm et al., Pretreatment with Prasugrel in Non?ST-Segment Elevation Acute Coronary Syndromes Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis, N Engl J Med, vol.369308, issue.1123, pp.2507-2523, 2012.

N. Assez, C. Adriansen, S. Charpentier, C. Baixas, J. Ducasse et al., Management of acute coronary syndromes without ST elevation: the TOSCANE registry. Arch Mal Coeur Vaiss, 2005.

P. Pour-un-infarctus-du-myocarde-?-j-eur-urgences-sauval, H. Bout, A. Ohanessian, N. Danchin, J. Monsegu et al., Management of chest pain by the Emergency Ambulance Service: the DOLORES register]. Arch Mal Coeur Vaiss, 1095? 9. 181. HAS-SAMU de France-SFMU-SFC. Prise en charge de l'infarctus du myocarde à la phase aiguë en dehors des services de cardiologie -Conférence de consensus, 2005.